IMAX CORP
Directors and executives of four companies sold shares. Agnico Eagle's Merfyn Roberts sold 1,500 shares at $273.35. ARC Resources' Sean Calder sold 10,000 shares at $33.89. Faraco's Daniel Simoncini sold 2M shares at $3.02. IMAX's Robert Lister sold 22,500 shares at $51.58. Proceeds ranged from $410K to $6M.
Imax Corp (IMAX) Chief Legal Officer Robert Lister sold 22,500 shares on 2026-09-10, according to an SEC filing. He now owns 204,875 shares. Over the past year, Lister sold 92,643 shares and made no purchases. Imax's stock trades at $51.58, with a P/E ratio of 71.36, and is considered significantly overvalued by GuruFocus. The company has seen 21 insider sells and 0 buys in the past year.
LISTER ROBERT D (Chief Legal Officer Sr Exec VP) sold 22,500 shares of IMAX CORP (IMAX) at $51.58 ($1.16M total) on 2026-09-10.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning IMAX (IMAX CORP). Coverage has skewed bearish: 0 bullish, 1 neutral, and 2 bearish.
Recent IMAX coverage spans financial news, earnings and insider activity.
In the last 30 days, IMAX insiders filed 8 SEC Form 4 transactions — no purchases and 8 sales ($29.1M). The most active reporter was GELFOND RICHARD L, Chief Executive Officer, with 3 filings. 38% of those filings were made under pre-arranged Rule 10b5-1 plans.
Executive sale could signal concerns for the entertainment tech firm.
Insider sale adds to a year‑long net selling trend, suggesting possible negative sentiment.
The insider sale may signal modest downside pressure on IMAX stock.
Disney reports 70% of 'Avengers: Doomsday' presales are for Infinity Vision screens, a new premium certification program launched after losing IMAX access. The film also incorporates real physics concepts like brane cosmology and plasma engineering. Infinity Vision requires specific technical standards and has seen strong early sales, suggesting brand loyalty over format preference. The article also discusses the scientific accuracy of the film's multiverse collision mechanics. (DIS)
Positive revenue outlook and expansion suggest upside potential.
AlphAI scores every news story that mentions IMAX with an AI model for sentiment and relevance, and aggregates insider trades from IMAX CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Directors and executives of four companies sold shares. Agnico Eagle's Merfyn Roberts sold 1,500 shares at $273.35. ARC Resources' Sean Calder sold 10,000 shares at $33.89. Faraco's Daniel Simoncini sold 2M shares at $3.02. IMAX's Robert Lister sold 22,500 shares at $51.58. Proceeds ranged from $410K to $6M.
2 min readImax Corp (IMAX) Chief Legal Officer Robert Lister sold 22,500 shares on 2026-09-10, according to an SEC filing. He now owns 204,875 shares. Over the past year, Lister sold 92,643 shares and made no purchases. Imax's stock trades at $51.58, with a P/E ratio of 71.36, and is considered significantly overvalued by GuruFocus. The company has seen 21 insider sells and 0 buys in the past year.
2 min readLISTER ROBERT D (Chief Legal Officer Sr Exec VP) sold 22,500 shares of IMAX CORP (IMAX) at $51.58 ($1.16M total) on 2026-09-10.
1 min readDisney reports 70% of 'Avengers: Doomsday' presales are for Infinity Vision screens, a new premium certification program launched after losing IMAX access. The film also incorporates real physics concepts like brane cosmology and plasma engineering. Infinity Vision requires specific technical standards and has seen strong early sales, suggesting brand loyalty over format preference. The article also discusses the scientific accuracy of the film's multiverse collision mechanics. (DIS)
3 min readIMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying
3 min readAnalysts updated price targets for several companies. Rosenblatt raised IMAX's target to $65, BTIG cut CAN's to $2, Piper Sandler adjusted TTAN and BRZE targets, Needham boosted VRNS, BTIG reduced BSX, Wedbush increased PHVS, Canaccord raised CHYM, Freedom Capital upped ABM, and Keybanc lifted INNV. All analysts maintained their respective ratings.
2 min readRosenblatt raised its price target for Imax (IMAX) to $65 from $60, citing record summer performance and strong box office results, including $322 million in August. The stock has risen 42.5% year-to-date. Imax reported Q2 earnings of $0.43 per share, up 65%, and revenue of $103 million, up 12%. The firm noted the film 'The Odyssey' drove significant box office returns.
2 min readHOYTS Cinemas and IMAX Corporation agreed to add 10 new IMAX with Laser locations in Australia and New Zealand, expanding their partnership. This deal will increase IMAX's footprint in the region to 14 locations by 2028. Both companies cited strong demand and performance of existing IMAX locations as key drivers. IMAX Australia reported record box office revenue of AUD 18.6 million in 2025.
2 min readIMAX CFO Natasha Fernandes sold 20,000 shares for $1.1M at $54.63/share, retaining 35,596 shares and 32,764 RSUs. IMAX has a $2.8B market cap, $416.1M TTM revenue, and +78% stock surge. Fernandes' sale is seen as routine, not a concern for investors.
2 min readStoneX maintained a Buy rating and $60 price target for IMAX (NYSE:IMAX), forecasting record Q3 box office revenue of $650M+ driven by strong performance of 'The Odyssey'. IMAX's Q2 earnings showed 65% YoY EPS growth to $0.43 and 12% revenue increase to $103M. Rosenblatt raised its target to $60, citing robust box office and system sales.
2 min read
